New booster shots designed to target the omicron variant and its subvariants, and the original strain of SARS-CoV-2, could become available in the U.S. in the coming weeks
Johns Hopkins researchers cite environmental changes caused by the pandemic, including adapting routines and less physical activity, as likely contributors to the increase in type 2 diabetes cases among children
A study, published in May, found some drugs approved by the FDA's "accelerated approval" program were available on the market for years without having verified clinical benefits
A lack of unified national regulation will not only slow the Biden administration's goal of reducing greenhouse gas emissions, but will also slow business investments and innovation, according to climate policy expert Paul Ferraro
A new platform designed by Hopkins researchers, in partnership with the University of Washington, shows promise in the sped up design of lipid nanoparticles to deliver treatments that prevent viral infections
Researchers examining the mechanics of drug dissolution and the natural anatomy of the stomach found that taking a pill while lying on your right side shortens the time it takes for medicine to be absorbed
Johns Hopkins epidemiologist David Dowdy says the guidance update brings the CDC in line with the habits of Americans and suggests we're closer to a new, endemic phase of COVID-19